Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Microorganisms|December 23, 2022
Eosinopenia as Predictor of Poor Outcome in Hospitalized COVID-19 Adult Patients from Waves 1 and 2 of 2020 PandemicRaphael Cauchois, Lea Pietri, Jean-Baptiste Dalmas, et al.Journal of Clinical Medicine|October 27, 2022
Impact of Dexamethasone and Inhaled Nitric Oxide on Severe Acute Kidney Injury in Critically Ill Patients with COVID-19Mickaël Bobot, David Tonon, Noémie Peres, et al.Journal of Intensive Care|November 11, 2025
Risk factors for nosocomial meningitis in patients with external ventricular drainagesColine Raffenot, Vincent Doat-Sarfati, François Antonini, et al.Kidney International Reports|June 20, 2024
Prospective Multicenter Study on Early Proximal Tubular Injury in COVID-19-Related Acute Respiratory Distress SyndromeMickaël Bobot, Xavier Heim, Howard Max, et al.Journal of Clinical Medicine|December 10, 2021
Factors Associated with 90-Day Mortality in Invasively Ventilated Patients with COVID-19 in Marseille, FranceMaxime Volff, David Tonon, Youri Bommel, et al.Frontiers in Immunology|August 10, 2019
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 PatientsCindy Marques, Julien Carvelli, Lucie Biard, et al.Nature|July 30, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axisJulien Carvelli, Olivier Demaria, Frédéric Vély, et al.Critical Care Medicine|October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.Autoimmunity Reviews|May 10, 2017
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patientsPierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, et al.Intensive Care Medicine|July 15, 2025
Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trialGuillaume Voiriot, Laurent Argaud, Yves Cohen, et al.Pageof 3